XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows from Operating Activities:    
Net income (loss) $ 5,034,465 $ (961,729) [1]
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (68,652) (40,510)
Change in fair value of derivative warrant liability (5,660,155) 333,500
Offering costs associated with warrants recorded as liabilities 379,848
Changes in operating assets and liabilities    
Prepaid expenses 159,432 (262,516)
Accrued expenses 42,178 214,025
Net cash used in operating activities (492,732) (337,382)
Cash Flows from Investing Activities:    
Proceeds from maturity of securities in Trust Account 175,073,579
Investment of cash in Trust Account (175,073,579) (175,000,000)
Net cash used in investing activities (175,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 171,500,000
Proceeds from sale of Founder Shares 25,000
Proceeds from sale of Private Warrants 6,150,000
Proceeds from promissory note – related party 150,000
Repayment of promissory note – related party (150,000)
Proceeds from underwriter’s rebate 175,000
Payment of offering costs (507,390)
Net cash provided by financing activities 177,342,610
Net Increase (Decrease) in Cash (492,732) 2,005,228
Cash – Beginning of period 2,005,228
Cash – End of period 1,512,496 2,005,228
Non-cash investing and financing activities:    
Deferred underwriting fee payable $ 6,125,000
[1] For the period from March 18, 2020 (inception) through December 31, 2020.